Live Breaking News & Updates on Trisalus Life Sciences Stock Down

Stay updated with breaking news from Trisalus life sciences stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated at Canaccord Genuity Group

Research analysts at Canaccord Genuity Group began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group’s target price would suggest a potential upside of 67.60% […] ....

Trisalus Life Sciences Company Profile , Canaccord Genuity Group , Tyche Wealth Partners , Trisalus Life Sciences Stock Down , Trisalus Life Sciences Inc , Trisalus Life Sciences , News Ratings For Trisalus Life Sciences Daily , Get Free Report , Marketbeat Ratings , Genuity Group , Salus Life Sciences Stock Down , Salus Life Sciences , Wealth Partners , Free Report , Pressure Enabled Drug Delivery , Pancreatic Retrograde Venous Infusion , Trisalus Life Sciences Daily ,

Canaccord Genuity Group Initiates Coverage on TriSalus Life Sciences (NASDAQ:TLSI)

Analysts at Canaccord Genuity Group began coverage on shares of TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) in a research note issued to investors on Thursday, Marketbeat reports. The firm set a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group’s price objective would suggest a potential upside of 67.60% […] ....

Hc Advisors , Trisalus Life Sciences Stock Down , Canaccord Genuity Group , Analysts At Canaccord Genuity Group , News Ratings For Trisalus Life Sciences Daily , Trisalus Life Sciences Inc , Trisalus Life Sciences , Get Free Report , Genuity Group , Salus Life Sciences Stock Down , Salus Life Sciences , Free Report , Pressure Enabled Drug Delivery , Pancreatic Retrograde Venous Infusion , Trisalus Life Sciences Daily ,